Beneficial effects of TX45, a long-acting Fc-relaxin fusion, on right ventricular-pulmonary artery coupling in patients with pulmonary hypertension due to HFrEF

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - heart failure with HFrEF (2) Heart Failure with Reduced Ejection Fraction (HFrEF) Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by